The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Changes In Market Value Are Expected For The Mitral Valve Disease Market Over The 2026–2030 Period?
The mitral valve disease market has exhibited robust growth in recent years. Its value is anticipated to rise from $3.28 billion in 2025 to $3.59 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.7%. The market’s past expansion is linked to factors such as the increasing prevalence of heart valve disorders, a growing reliance on echocardiography diagnostics, an uptick in surgical mitral valve repair procedures, the adoption of anticoagulation therapies, and enhancements in hospital cardiac care infrastructure.
The mitral valve disease market is anticipated to show significant expansion in the coming years, with its size projected to reach $5.01 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.6%. This growth during the forecast period is attributable to the increasing availability of minimally invasive mitral valve procedures, a rising demand for TMVR solutions, the growing adoption of remote cardiac monitoring, increased investment in valve repair devices, and the development of personalized therapeutic approaches. Major trends expected over the forecast period include advancements in precision medicine-based mitral valve therapies, the integration of AI in mitral valve diagnostics and monitoring, the expansion of cloud-based cardiac imaging and data platforms, the uptake of IoT-enabled remote cardiac monitoring devices, and a greater use of robotic-assisted mitral valve repair systems.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16480&type=smp
What Primary Drivers Are Shaping The Mitral Valve Disease Market?
The expanding occurrence of vascular heart conditions is projected to boost the future expansion of the mitral valve disease market. These conditions include various ailments impacting the blood vessels that deliver blood to the heart or are situated within the heart. The rising incidence of vascular heart diseases stems from a sophisticated combination of lifestyle decisions, shifts in demographics, existing medical issues, surrounding environmental elements, and genetic factors. Conditions like ischemic heart disease and hypertension, which are types of vascular heart diseases, can indirectly contribute to mitral valve disease by impairing the heart’s structural integrity and operational capacity, thereby creating circumstances detrimental to the mitral valve. As an illustration, data from November 2024, provided by the Scottish Government, a governmental body located in Scotland, indicates that the prevalence of any cardiovascular disease among adult populations increases significantly with advancing age, achieving 42% in individuals who are 75 years old or older. Consequently, the growing frequency of vascular heart diseases is fueling the mitral valve disease market.
How Is The Mitral Valve Disease Market Organized By Segment Classification?
The mitral valve disease market covered in this report is segmented –
1) By Treatment Type: Mitral Valve Repair, Mitral Valve Replacement, Mitral Valve Therapeutics
2) By Indication: Mitral Valve Stenosis, Mitral Valve Prolapse, Mitral Valve Regurgitation
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Mitral Valve Repair: Surgical Repair, Minimally Invasive Repair, Percutaneous Mitral Valve Repair
2) By Mitral Valve Replacement: Mechanical Valve Replacement, Biological Valve Replacement, Transcatheter Mitral Valve Replacement (TMVR)
3) By Mitral Valve Therapeutics: Pharmacological Treatments, Anticoagulation Therapy, Mitral Valve Repair Devices
What Trends Are Affecting The Growth Of The Mitral Valve Disease Market?
Leading companies in the mitral valve disease market are focusing on developing stented tissue valves to meet the growing demand for less invasive treatment options. These stented tissue valves are engineered to offer durable and reliable performance, providing patients with an alternative to traditional surgical interventions. For example, in April 2024, Medtronic, an Ireland-based healthcare firm, launched the Avalus Ultra valve, an advanced surgical aortic tissue valve designed for greater ease of use during both implantation and long-term patient management. Building on a decade of clinical experience with the original Avalus valve, the Avalus Ultra features a low valve profile to simplify implantation, a PEEK base frame for consistent circularity, and an industry-leading Effective Orifice Area (EOA) which may promote enhanced blood flow. Additionally, it incorporates a radiopaque coil for clear visibility during future valve-in-valve procedures.
Who Are The Industry Participants Involved In The Mitral Valve Disease Market?
Major companies operating in the mitral valve disease market are Pfizer Inc., Bayer AG, Abbott Laboratories, Novartis AG, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences, ShockWave Medical Inc., Artivion Inc., TTK Health Care Limited, Braile Biomedica, JenaValve Technology Inc., 4C Medical technologies, Labcor Laboratorios Ltda, CryoLife Inc., Valcare Medical, Affluent Medical, Colibri Heart Valve LLC, Coramaze Technologies, Corcym UK Limited, HighLife Medical, Micro International Devices Inc., Neovasc Inc., Mitralign Inc., Transcatheter Technologies GmbH
Get The Full Mitral Valve Disease Market Report:
https://www.thebusinessresearchcompany.com/report/mitral-valve-disease-global-market-report
Which Region Dominates The Mitral Valve Disease Market By Market Share?
Europe was the largest region in the mitral valve disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mitral valve disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Mitral Valve Disease Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/mitral-valve-disease-global-market-report
Browse Through More Reports Similar to the Global Mitral Valve Disease Market 2026, By The Business Research Company
Next Generation Antibody Therapeutics Market Report 2026
Mammalian Polyclonal Immunoglobulin G Igg Antibody Market Report
Recombinant Proteins Market Report
https://www.thebusinessresearchcompany.com/report/recombinant-proteins-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model